Repeat Sentinel Lymph Node Biopsy in Ipsilateral Breast Tumor Recurrence

Status Recruiting

Clinical Trial Summary

According to the standard treatment guidelines established until recently, in the case of ipsilateral breast tumor recurrence without systemic metastasis, salvage mastectomy or lumpectomy can be performed when either partial or whole breast radiation therapy is possible. On the other hand, there are currently no standard treatment guidelines for axillary treatment, and the evidence for this is limited. Axillary lymph node metastasis was reported to occur in about 26% of breast cancer patients who had negative sentinel lymph nodes from previous surgery for primary breast cancer and only local recurrence occurred. It is still important in the decision of treatment or adjuvant radiation therapy. However, it is known that most of the patients with ipsilateral breast recurrence do not have axillary lymph node metastasis. Therefore, performing axillary axillary surgery in all of these patients does not help the patient's survival in many cases, but rather can lead to complications such as lymphedema and seroma and postoperative wound infection. A question about the implementation of axillary lymph node resection has been raised and for this reason, it is necessary to study whether surveillance lymph node biopsy is still effective in patients with recurrence in the ipsilateral breast. Most of the studies on ipsilateral breast tumor recurrence without systemic metastasis reported to date are case reports or small retrospective studies. In addition, the combined meta-analysis also has limitations in that the study design is not uniform, and there are many cases in which primary breast cancer surgery performed total mastectomy or axillary lymph node dissection. This study is a multicenter prospective study designed to validate the clinical effectiveness of repeat-SLNB conducted in patients with ipsilateral breast tumor recurrence among patients who previously underwent breast conservation and sentinel lymph node biopsy for unilateral primary breast cancer.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04741737
Study type	Interventional
Source	Gangnam Severance Hospital
Contact	Soong June Bae, M.D.
Phone	82-2-2019-4401
Email	mission815815@yuhs.ac
Status	Recruiting
Phase	N/A
Start date	March 1, 2020
Completion date	January 31, 2029

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03618433` - KİNECT® - Video Games Based Physiotherapy Programme in Patients With Breast Cancer Surgery	N/A
Terminated	`NCT05395936` - Mastectomy Flap Temperature Study	N/A
Recruiting	`NCT03757793` - Near-infrared Spectroscopy for Monitoring Tissue Oxygenation in Breast Reconstruction
Completed	`NCT01781299` - Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU	Phase 4
Completed	`NCT01176786` - Reusable Versus Disposable Draping System in Breast Reconstruction Surgery	N/A
Terminated	`NCT00616824` - The Use of an Acellular Dermal Matrix in a Two-Staged Breast Reconstruction	Phase 4
Recruiting	`NCT06033456` - Combining Stellate Ganglion and T2 and T3 Radiofrequency Ablation on Post-mastectomy Complex Regional Pain Syndrome	N/A
Recruiting	`NCT05975359` - Assessment of the Interi Manifold in Implant-Based Breast Reconstruction	N/A
Withdrawn	`NCT03135392` - Sensation After Nipple Sparing Mastectomy and Breast Reconstruction With or Without Neurotized Free Tissue Transfer	N/A
Recruiting	`NCT01217593` - Ultrasound vs. Predetermined Distance Techniques for Paravertebral Nerve Block in Patients Having Breast Surgery	N/A
Completed	`NCT01231204` - Prevention of Post-Mastectomy Breast Pain Using Ambulatory Continuous Paravertebral Blocks	Phase 4
Recruiting	`NCT05069805` - Comparison of Erector Spinae Plane Block and Pectoral Nerve Block for Acute and Chronic Pain in Mastectomies	N/A
Completed	`NCT01687348` - Lidocaine Pharmacokinetics During Tumescent Infiltrative Anaesthesia for Mastectomy	Phase 3
Completed	`NCT00555503` - Registry of Mastectomy for Breast Cancer Risk Reduction	N/A
Recruiting	`NCT03598712` - Local Compression Seroma DIminution Objective (CLODIS)	Phase 3
Not yet recruiting	`NCT04457167` - Mastectomy With Retention of the Nipple-areola Complex, Robot-assisted or Not, and / or Immediate or Seconday Reconstruction by Latissimus Dorsi Flap, Robot-assisted or Not.	N/A
Recruiting	`NCT05494502` - Impact of Erector Spinae Plane Block on Chronic Postsurgical Pain in Breast Cancer Patients	N/A
Recruiting	`NCT02894021` - PREvention of Post-mastectomy LYMphoceles by PAdding	N/A
Recruiting	`NCT04891510` - A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery	N/A
Enrolling by invitation	`NCT05658367` - Effect of Aromatherapy Massage on Pain and Anxiety After Mastectomy	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.